S-14,506

From WikiMD's WELLNESSPEDIA

S-14,506

0S-14,506 is a pharmacological compound that belongs to the class of serotonin receptor agonists. It is specifically a 5-HT1A receptor agonist, which means it binds to and activates this specific subtype of serotonin receptors in the brain.

Pharmacology[edit]

S-14,506 is a potent and selective 5-HT1A receptor agonist. The 5-HT1A receptor is one of the several different types of receptors for serotonin, a key neurotransmitter in the brain. Activation of 5-HT1A receptors has been linked to a variety of therapeutic effects, including anxiolytic and antidepressant effects.

Therapeutic Use[edit]

While S-14,506 itself is not used clinically, it has been extensively studied in preclinical research as a tool to understand the role of 5-HT1A receptors in various neuropsychiatric disorders. These include depression, anxiety disorders, and schizophrenia.

Chemistry[edit]

S-14,506 is a synthetic compound. Its chemical structure is distinct from that of serotonin, but it has been designed to bind to the same receptors in the brain.

Research[edit]

Research on S-14,506 has contributed to our understanding of the role of 5-HT1A receptors in the brain. For example, studies using this compound have shown that activation of these receptors can have potent antidepressant and anxiolytic effects. This has led to the development of several clinically used drugs that also target these receptors.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.